The Global 4-Acetamidopiperidine Market was valued at USD 45.6 Million in 2023 and is projected to reach USD 68.3 Million by 2029, growing at a Compound Annual Growth Rate (CAGR) of 5.8% during the forecast period (2023–2029). This organic compound (CAS#5810-56-0, C7H14N2O) serves as a crucial pharmaceutical intermediate in drug synthesis, particularly for CNS medications and pain management therapies.
As pharmaceutical R&D intensifies globally, demand for high-purity specialized intermediates continues to rise. This blog profiles the Top 10 Companies in the 4-Acetamidopiperidine Industry—a mix of established chemical manufacturers and specialized pharmaceutical ingredient suppliers shaping this niche market.
🔟 1. Unichemist
Headquarters: Hangzhou, China
Key Offering: Purity ≥98% 4-Acetamidopiperidine
Unichemist dominates the market with vertically integrated production capabilities and GMP-certified facilities. The company supplies pharmaceutical-grade intermediates to over 30 countries, with rigorous QC standards that meet international pharmacopeia requirements.
Competitive Advantages:
-
Annual production capacity exceeding 500 metric tons
-
Strict ISO 9001:2015 certified manufacturing processes
-
Patent-pending purification technologies
Download FREE Sample Report: 4-Acetamidopiperidine Market – View in Detailed Research Report
9️⃣ 2. Win-Win Chemical
Headquarters: Shanghai, China
Key Offering: Pharmaceutical Intermediates including 4-Acetamidopiperidine
This specialty chemical manufacturer has demonstrated consistent growth in the API intermediates segment. Their R&D focus on piperidine derivatives positions them as a preferred supplier for neurologic drug developers.
Competitive Advantages:
-
Custom synthesis capabilities for modified derivatives
-
Strategic partnerships with major pharma companies
8️⃣ 3. Aromsyn
Headquarters: Wuhan, China
Key Offering: High-purity heterocyclic compounds
Aromsyn has carved a niche in fine chemicals with its proprietary catalysis processes for nitrogen-containing heterocycles. Their 4-Acetamidopiperidine production maintains impurity levels below 0.5%.
Competitive Advantages:
-
Advanced analytical QC laboratories
-
REACH and FDA DMF compliant documentation
7️⃣ 4. INNOPHARMCHEM
Headquarters: Nanjing, China
Key Offering: cGMP-grade pharmaceutical intermediates
INNOPHARMCHEM serves multinational pharma clients with regulatory-ready intermediates. Their continuous flow chemistry technology allows for scalable 4-Acetamidopiperidine production.
Competitive Advantages:
-
Dedicated kilo lab for small-batch productions
-
ICH stability testing capabilities
Download FREE Sample Report: 4-Acetamidopiperidine Market – View in Detailed Research Report
6️⃣ 5. Shanghai Canbi Pharma
Headquarters: Shanghai, China
Key Offering: API intermediates and building blocks
Specializing in nitrogen-rich pharmaceutical compounds, Canbi Pharma offers both standard and custom-synthesized 4-Acetamidopiperidine with batch-to-batch consistency.
Competitive Advantages:
-
Dual sourcing strategy ensures supply continuity
-
Comprehensive safety and toxicology data packages
5️⃣ 6. Hairui
Headquarters: Zhengzhou, China
Key Offering: Heterocyclic compounds for drug discovery
Hairui Chemical serves the early-phase drug development market with flexible small-quantity supplies of 4-Acetamidopiperidine and related scaffolds.
Competitive Advantages:
-
Rapid turnaround for research quantities
-
Structure-activity relationship expertise
4️⃣ 7. Fuxin Pharmaceutical
Headquarters: Liaoning, China
Key Offering: cGMP intermediates for CNS drugs
This specialist manufacturer focuses on intermediates for neurologic medications, with particularly strong IP protection for its 4-Acetamidopiperidine production methods.
Competitive Advantages:
-
Controlled substance manufacturing licenses
-
Dedicated high-potency production suites
3️⃣ 8. Energy Chemical
Headquarters: Shanghai, China
Key Offering: Catalog and custom fine chemicals
Energy Chemical supplies both pharmaceutical and academic researchers through its extensive catalog of building blocks, including multiple purity grades of 4-Acetamidopiperidine.
Competitive Advantages:
-
Inventory-backed rapid delivery
-
Technical support for medicinal chemists
2️⃣ 9. Tokyo Chemical Industry (TCI)
Headquarters: Tokyo, Japan
Key Offering: High-purity research chemicals
TCI maintains strict quality standards for its 4-Acetamidopiperidine, serving global pharmaceutical and biotechnology research organizations.
Competitive Advantages:
-
Extensive analytical characterization data
-
Global distribution network
1️⃣ 10. Capot Chemical
Headquarters: Hangzhou, China
Key Offering: API intermediates and functional compounds
Capot completes our list with its focus on cost-efficient production of nitrogen heterocycles while maintaining strict impurity control standards.
Competitive Advantages:
-
Process optimization expertise
-
Competitive pricing through operational efficiency
Get Full Report Here: 4-Acetamidopiperidine Market – View in Detailed Research Report
🔬 Outlook: Pharmaceutical Intermediates Market Poised for Growth
The 4-Acetamidopiperidine market reflects broader trends in pharmaceutical ingredient manufacturing, with increasing demands for:
📈 Key Market Drivers:
-
Growing pipeline of CNS-targeting therapeutics
-
Increasing outsourcing by pharmaceutical companies
-
Stricter regulatory requirements for impurity profiles
-
Advancements in catalytic synthesis methods
As drug developers pursue more complex molecular targets, intermediates like 4-Acetamidopiperidine will continue playing a critical role in small molecule drug development pipelines worldwide.
Get Full Report Here: 4-Acetamidopiperidine Market – View in Detailed Research Report
- Heating Cable for Ice and Snow Market, Global Outlook and Forecast 2023-2030 - September 15, 2025
- Top 10 Companies in the Cryogenic Adhesive Industry (2025): Market Leaders Powering Extreme-Temperature Applications - September 15, 2025
- 2023-2028 Global and Regional Flexible Laminations Adhesives Industry Status and Prospects Professional Market Research Report Standard Version - September 15, 2025